Clavis Pharma ASA

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Clavis Pharma ASA Company Summary

COMPANY DATA

	Homepage	www.clavispharma.com

---

Key Developments: Clavis Pharma ASA

	Clavis Pharma ASA (OSL:CLAVIS) THIRD QUARTER REPORT 2008 OCT 23, 2008 16:05 - Article Views: 208 Clavis Pharma ASA (OSL:CLAVIS) "Three products in clinical development" Oslo, Norway, October 23, 2008
	Clavis Pharma ASA (OSL:CLAVIS) Clavi S Pharma - Presentation Of Third Quarter 2008 Results OCT 20, 2008 22:31 - Article Views: 627 Clavis Pharma ASA (OSL:CLAVIS) Clavis Pharma ASA (CLAVIS) will present its third quarter 2008 results on Thursday 23 October 2008 at Hotel Continental, Stortingsgaten 24/26 (Meeting Room 4).
	Clavis Pharma ASA (OSL:CLAVIS) Oral Anticancer Drug CP-4126 Enters Clinical Phase I Study OCT 7, 2008 16:05 - Article Views: 303 Clavis Pharma ASA (OSL:CLAVIS) Oslo, Norway, 7 October 2008
	Clavis Pharma ASA (OSL:CLAVIS) Promising Clinical Phase I Results For Intravenous CP-4126 Presented At ESMO SEP 15, 2008 15:47 - Article Views: 338 Clavis Pharma ASA (OSL:CLAVIS) Oslo, Norway, September 15, 2008 Clavis Pharma ASA (OSE: CLAVIS) announced today that promising results from its Intravenous CP-4126 Phase I study in patients with solid tumours have been presented at the European Society for Medical Oncology (ESMO) Meeting 2008. The presentation was held on 13 September.
	Clavis Pharma ASA (OSL:CLAVIS) REPORT FOR SECOND QUARTER AND FIRST-HALF YEAR 2008 AUG 22, 2008 15:33 - Article Views: 503 Clavis Pharma ASA (OSL:CLAVIS) Clinical development of ELACYT in haematology expanded
	Clavis Pharma ASA (OSL:CLAVIS) INVITATION TO PRESENTATION OF CLAVIS PHARMA'S SECOND QUARTER RESULTS 2008 AUG 19, 2008 18:03 - Article Views: 266 Clavis Pharma ASA (OSL:CLAVIS) Oslo, Norway, 19 August 2008
	ELACYT(TM) Clinical Update JULY 30, 2008 00:19 - Article Views: 664 Clavis Pharma ASA Oslo, Norway, 29 July 2008 Clavis Pharma (OSE: CLAVIS) announced today that it is amending its clinical program for ELACYT following an evaluation of all clinical data available for ELACYT(TM), both in haematology and solid tumours.
	Employee Stock Option Plan JULY 1, 2008 01:03 - Article Views: 652 Clavis Pharma ASA Oslo, Norway, 30 June 2008
	Promising Results For Oral CP-4126 JUNE 26, 2008 00:05 - Article Views: 225 Clavis Pharma ASA Oslo, Norway, 25 June 2008
	CLAVIS PHARMA RECEIVES US ORPHAN DRUG DESIGNATION FOR ELACYT(TM) JUNE 25, 2008 16:03 - Article Views: 277 Clavis Pharma ASA Clavis Pharma Receives US Orphan Drug Designation for ELACYT(TM) Oslo, Norway, June 25, 2008

123 COMPANY PROFILE VIEWS

This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 9) (Since Published: 123)